Cytomegalovirus (CMV) Infection in Pregnancy

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT00194155
Collaborator
(none)
283
1
57.1
5

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if (recurrent) cytomegalovirus (CMV) infection of the mother results in pregnancy complications such as preterm delivery, severe preeclampsia, poor fetal growth, or stillbirth.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    CMV infection in adults with a normal immune system is rarely a serious event. Once a person has been infected with CMV, they may have recurrences (relapses) of the infection. If a mother is infected with the virus or relapses during pregnancy, her fetus may be at risk for infection. Unlike infection in adults, fetal infection may result in serious complications (congenital infection). The effects of fetal infection with CMV are well understood and many efforts have been made to potentially reduce the risk of congenital infection. However, the effect of CMV infection on the pregnancy itself (when the fetus is not affected by CMV) is less understood.

    In this study, we plan to determine if CMV recurrence in the mother results in pregnancy complications. The pregnancy complications listed above have been associated with poor placental function. We also plan to determine if (recurrent) CMV infection in the mother is associated with CMV infection of the placenta.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    283 participants
    Observational Model:
    Case-Only
    Official Title:
    Cytomegalovirus Infection and Pregnancy Outcomes
    Study Start Date :
    May 1, 2003
    Actual Primary Completion Date :
    Feb 1, 2008
    Actual Study Completion Date :
    Feb 1, 2008

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      15 Weeks and Older
      Sexes Eligible for Study:
      Female
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Women who deliver at term without pregnancy complications

      • Women who deliver (preterm, less than 37 weeks gestation) as a result of spontaneous preterm labor

      • Women whose pregnancies are complicated by severe preeclampsia

      • Women whose pregnancies are complicated by unexplained poor fetal growth (less than the 10th percentile).

      • Women whose pregnancies are complicated by unexplained stillbirth.

      Exclusion Criteria:
      • Women with multi-gestational pregnancies, or whose pregnancies are complicated by a congenital malformation or chromosomal abnormality.

      • Women who have a medical history of hypertension (high blood pressure), diabetes, or severe renal (kidney) disease

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Hospital of the University of Pennsylvania Philadelphia Pennsylvania United States 19104

      Sponsors and Collaborators

      • University of Pennsylvania

      Investigators

      • Principal Investigator: Samuel Parry, MD, University of Pennsylvania

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      University of Pennsylvania
      ClinicalTrials.gov Identifier:
      NCT00194155
      Other Study ID Numbers:
      • R01 17625-03-13
      First Posted:
      Sep 19, 2005
      Last Update Posted:
      Aug 17, 2016
      Last Verified:
      Aug 1, 2016
      Keywords provided by University of Pennsylvania
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Aug 17, 2016